Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec 15;14(24):8495-505.
doi: 10.1016/j.bmc.2006.08.042. Epub 2006 Oct 11.

Modification at the C9 position of the marine natural product isoaaptamine and the impact on HIV-1, mycobacterial, and tumor cell activity

Affiliations

Modification at the C9 position of the marine natural product isoaaptamine and the impact on HIV-1, mycobacterial, and tumor cell activity

Waseem Gul et al. Bioorg Med Chem. .

Abstract

As part of an investigation to generate optimized drug leads from marine natural pharmacophores for the treatment of neoplastic and infectious diseases, a series of novel isoaaptamine analogs were prepared by coupling acyl halides to the C9 position of isoaaptamine (2) isolated from the Aaptos sponge. This library of new semisynthetic products was evaluated for biological activity against HIV-1, Mtb, AIDS-OI, tropical parasitic diseases, and cancer. Compound 4 showed potent activity against HIV-1 (EC(50) 0.47microg/mL), compound 19 proved to possess remarkable activity against Mycobacterium intracellulare with an IC(50) and MIC value of 0.15 and 0.31microg/mL, while compounds 4 and 17 possessed anti-leishmanial activity with IC(50) values of 0.1 and 0.4microg/mL, respectively. Compounds 16 and 17 showed antimalarial activity with EC(50) values of 230 and 240ng/mL, respectively, and compound 14 exhibited an EC(50) of 0.05microM against the Leukemia cell line K-562.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Aaptamine related structures.

References

    1. Nakamura H, Kobayash J, Ohizumi Y, Hirata Y. Tetrahedron Lett. 1982;23:5555–5558.
    1. Ohizumi Y, Kajiwara A, Nakamura H, Kobayashi J. J Pharm Pharmacol. 1984;36:785–786. - PubMed
    1. Fedoreev S, Prokofeva N, Denisenko V, Rebachuk N. Khim Farm Zh. 1988;22:943.
    1. Kashman Y, Rudi A, Hirsh S, Isaacs S, Green D, Blasberger D, Carmely S. New J Chem. 1990;14:729–740.
    1. Shen Y, Chein C, Hsieh P, Duh C. Taiwan Shuichan Xuehuikan. 1997;24:117.

Publication types

MeSH terms